{"id":"NCT01026831","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED)","officialTitle":"A Phase III, Randomized, Active Comparator-Controlled, Twelve-Week, Double-Masked Clinical Trial to Compare the Efficacy and Safety of Preservative-Free MK2452 (0.0015%) and Preservative-Free Timolol Maleate (0.5%) in Patients With Open-Angle Glaucoma and Ocular Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-01-06","primaryCompletion":"2010-09-17","completion":"2010-09-17","firstPosted":"2009-12-04","resultsPosted":"2011-09-13","lastUpdate":"2017-06-21"},"enrollment":643,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Open-angle Glaucoma","Ocular Hypertension"],"interventions":[{"type":"DRUG","name":"Preservative-Free Tafluprost","otherNames":["MK2452"]},{"type":"DRUG","name":"Comparator: timolol","otherNames":[]}],"arms":[{"label":"Tafluprost","type":"EXPERIMENTAL"},{"label":"timolol maleate","type":"ACTIVE_COMPARATOR"}],"summary":"This study was to compare the safety and efficacy of the preservative-free formulation of 0.0015% MK2452 (tafluprost) and preservative-free 0.5% timolol maleate in patients with open-angle glaucoma and ocular hypertension. This study was to demonstrate that the preservative-free formulation of 0.0015% tafluprost is non-inferior to preservative-free 0.5% timolol maleate.","primaryOutcome":{"measure":"Mean Intraocular Pressure (IOP) Change From Baseline at All 9 Time Points During the Study (0800, 1000 and 1600 Hrs at Weeks 2, 6, and 12)","timeFrame":"Baseline, Weeks 2, 6, and 12.","effectByArm":[{"arm":"Tafluprost","deltaMin":-7.1,"sd":null},{"arm":"Timolol Maleate","deltaMin":-6.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":11},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["22310086"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":320},"commonTop":[]}}